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ABSTRACT
Aspergillus fumigatus is an important fungal pathogen of the immunocompromised host. Innate inflammatory and
adaptive T cell responses contribute to defense against this pathogen. Toll-like receptors are involved in the
activation of innate immune defenses against fungal spores and hyphae and contribute to the recruitment of
inflammatory cells to sites of infection. T cell responses to A. fumigatus are rapid and robust, and their differen-
tiation is influenced by themetabolic activity of spores. Ongoing investigations of immune responses toA. fumigatus
are likely to provide opportunities to enhance defenses against this pathogen in the immunocompromised host.
© 2006 American Society for Blood and Marrow Transplantation
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iNTRODUCTION
Aspergillus fumigatus is a spore-forming mold that is
ommon in the environment. Aspergillus fumigatus
pores, referred to as conidia, are 2 to 3 m in diameter,
nd their surface is highly hydrophobic, thus allowing
hem to remain aﬂoat in the air for prolonged periods of
ime [1]. Conidia are frequently inhaled, and some esti-
ates suggest that roughly 2000 conidia lodge in the
erminal airways every day. In most individuals, inhala-
ion of A. fumigatus conidia is innocuous. Conidia that
ccess terminal airways are phagocytosed and killed by
lveolar macrophages in a phagocyte oxidase–dependent
anner [2]. There is evidence that alveolar macrophages
nd dendritic cells can carry A. fumigatus conidia to the
ediastinal lymph nodes [3]. Aspergillus fumigatus
onidia that are not killed by alveolar macrophages ac-
ivate a program of swelling and gene transcription [4].
n the setting of steroid therapy, macrophage function is
ufﬁciently disabled to permit conidial germination and
he formation of hyphae [5]. Hyphae can grow rapidly
nd destroy mammalian tissues, thus enabling fungal
nvasion of tissues and the vasculature and leading to
ematogenous dissemination. Although conidial ger-
ination is largely controlled by macrophages, hy-
hal invasion of tissues is restricted by neutrophil
ecruitment and activation [5,6]. Thus, invasive dis-
ase caused by A. fumigatus is seen in patients with
igniﬁcant degrees of immunocompromise. p
B&MTNVASIVE ASPERGILLOSIS AFTER ALLOGENEIC
EMATOPOIETIC STEM CELL TRANSPLANTATION
Patients undergoing bone marrow transplanta-
ion are highly vulnerable to invasive fungal infec-
ion [7-10]. Invasive aspergillosis occurs in 5% to
0% of patients undergoing allogenic stem cell trans-
lantation and thus is a clinically important and com-
on problem [11]. Although neutrophils play an im-
ortant role in defense against A. fumigatus
nfection, bone marrow transplantation patients re-
ain vulnerable to pulmonary infection with this
athogen long after neutrophils have returned [11-
4]. It is likely that defective T-lymphocyte re-
ponses contribute to the enhanced susceptibility of
one marrow transplantation patients to invasive
ungal diseases at these later time points. Patients
ith progressive invasive A. fumigatus infection
ave decreased T-cell proliferation and diminished
nterferon (IFN)– responses compared with pa-
ients with resolved fungal infections [15]. In a
ouse model of allogeneic bone marrow transplan-
ation, immunization with dendritic cells and A. fu-
igatus conidia induced T-helper type 1 (Th1) CD4
-cell responses that conferred enhanced resistance to
nvasive fungal disease [16]. These studies suggest that
D4 T cells, particularly in the setting of the highly
mmunocompromised host, can provide substantial
rotection against invasive fungal disease.
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4SPERGILLUS FUMIGATUS–SPECIFIC CD4 T-CELL RESPONSES
Exposure to A. fumigatus can induce either Th1 or
h2 CD4 T-cell responses, depending on the circum-
tances of antigen exposure. Invasive A. fumigatus infec-
ion is enhanced when IFN- or tumor necrosis factor
TNF) is inhibited, thus suggesting that CD4 Th1 cells
rotect against fungal invasion [17,18]. Indeed, transfer
f CD4 T cells from A. fumigatus immunized to suscep-
ible mice confers resistance to conidia challenge [19].
efense against invasive A. fumigatus infection is im-
aired by interleukin (IL)–4, and mice lacking this cy-
okine are more resistant to fungal invasion [20]. In
ontrast, IL-10 depletion during challenge enhances
ungal clearance by increasing the expression of IL-12
nd IFN-—cytokines that play a positive role in de-
ense against A. fumigatus [21]. At the level of macro-
hages, IL-10 decreases killing ofA. fumigatus conidia by
mpairing the oxidative burst [22].
Studies of A. fumigatus–speciﬁc T-cell responses
fter infection with live fungus have been limited by
he in vitro outgrowth of mold in T-cell cultures.
ecent work has demonstrated that the addition of
oriconazole to T-cell cultures prevents the growth of
. fumigatus in T-cell cultures without affecting T-cell
roliferation or differentiation [23]. Pulmonary infec-
ion of mice with live A. fumigatus conidia rapidly
rimes CD4 T cells in draining mediastinal lymph
odes and results in recruitment of activated effector
cells into the airways within 7 days [24]. In excess of
% of CD4 T cells in bronchoalveolar lavage ﬂuid
roduce IFN- upon stimulation with A. fumigatus
ntigens, thus suggesting that the frequency of fun-
us-speciﬁc CD4 T cells is quite high. In contrast to
ive A. fumigatus spores, which induce Th1 CD4 T
ells, killed fungal spores prime CD4 T cells that
roduce more IL-4 and IL-13 [24]. These studies
uggest that the innate inﬂammatory response in-
uced by live fungal spores inﬂuences the differentia-
ion of responding CD4 T cells.
NNATE IMMUNE RESPONSES AGAINST
SPERGILLUS FUMIGATUS
Inhalation of A. fumigatus conidia results in the in-
uction of TNF, IL-12, IL-18, and IFN- in bronchoal-
eolar lavage ﬂuid and in the pulmonary parenchyma,
nd antibody-mediated depletion of these cytokines in
ice delays pulmonary clearance of A. fumigatus [25].
NF seems to be of particular importance, because
ntibody-mediated blockade of TNF in immunocompe-
ent and immunocompromised mice exacerbates pulmo-
ary A. fumigatus infection [17]. In vivo TNF depletion
esulted in decreased pulmonary myeloperoxidase activ-
ty and decreased production of chemokines that recruit
nﬂammatory cells to the lung, such as macrophage in-
ammatory protein-2, KC, and Mip-1 [17]. Anecdotal i
8eports suggest that blocking TNF in humans with in-
iximab enhances susceptibility to pulmonary A. fumiga-
us infection [17,26,27]. Whereas some studies suggest
hat TNF is involved in the recruitment of inﬂammatory
ells to the lung [17,28], other studies suggest that TNF
nhances the ability of recruited neutrophils to kill A.
umigatus hyphae, most likely by enhancing superoxide
roduction [29].
Although numerous studies have demonstrated ro-
ust cytokine and chemokine induction in macrophages
xposed to A. fumigatus conidia, relatively little is known
bout the recognition of A. fumigatus by receptors of the
nnate immune system. Some recent in vitro studies,
owever, demonstrate that toll-like receptors (TLRs)
nd the associated adaptor molecules play at least a par-
ial role in mediating the inﬂammatory response to A.
umigatus. The ﬁrst study to implicate TLRs in A. fu-
igatus recognition demonstrated that antibody-medi-
ted blockade of CD14 or TLR4, but not TLR2, de-
reased TNF production by human monocytes [30].
ore recent studies using murine cells suggested that
LR4 mediates signals in response to A. fumigatus
onidia, as measured by TNF production, but not in
esponse to hyphae. TLR2, conversely, was involved in
he recognition of both conidia and hyphae [31]. Studies
f peritoneal macrophages indicate that TLR2, and not
LR4, is involved in the induction of TNF by A. fu-
igatus hyphae and conidia and that this process is
yD88 dependent [32]. This study contrasts with an-
ther study demonstrating that both TLR2 and TLR4
ediate nuclear factor-B activation upon exposure to
. fumigatus hyphae and conidia [33]. In yet another
tudy of innate immune defense against A. fumigatus,
one marrow–derived macrophages were found to se-
rete TNF and kill A. fumigatus conidia in a MyD88-
ndependent fashion [34]. Many factors, such as the ac-
ivation status of the macrophages, the origin of the
acrophages, and the fungal strains, may account for the
pparently disparate results from these different studies.
ecently, the induction of TLR expression was investi-
ated in human and mouse neutrophils; complex regu-
ation of the expression of TLR1, 2, 4, 6, 9, and 10 on
eutrophils was demonstrated after exposure to A. fu-
igatus conidia and hyphae [35]. It is important to note
hat these studies also demonstrated that TLR4 played
n important role in the response of neutrophils to A.
umigatus.
UMMARY
Invasive fungal infections remain an important com-
lication after allogeneic hematopoietic stem cell trans-
lantation. Laboratory investigations of immune re-
ponses to A. fumigatus infection are likely to provide
ew insights that will enhance the treatment of invasive
ungal disease in the immunocompromised host. Specif-
cally, future studies are likely to determine which cellu-
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Immune Responses to Aspergillus fumigatus Infections
Bar components of the innate inﬂammatory response and
f the CD4 T-cell response enable inhibition of in vivo
ungal growth and, ultimately, fungal killing.
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